According to Virax Biolabs's latest financial reports the company has $5.1 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $9.35 M | 42888.32% |
2022-03-31 | $0.02 M | 23.47% |
2021-03-31 | $0.01 M | -22.06% |
2020-03-31 | $0.02 M |